DK194377A - Pyrrolidoner samt deres fremstilling og anvendelse - Google Patents
Pyrrolidoner samt deres fremstilling og anvendelseInfo
- Publication number
- DK194377A DK194377A DK194377A DK194377A DK194377A DK 194377 A DK194377 A DK 194377A DK 194377 A DK194377 A DK 194377A DK 194377 A DK194377 A DK 194377A DK 194377 A DK194377 A DK 194377A
- Authority
- DK
- Denmark
- Prior art keywords
- pyrrolidones
- manufacture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762619638 DE2619638A1 (de) | 1976-05-04 | 1976-05-04 | Pyrrolidone und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK194377A true DK194377A (da) | 1977-11-05 |
Family
ID=5977020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK194377A DK194377A (da) | 1976-05-04 | 1977-05-03 | Pyrrolidoner samt deres fremstilling og anvendelse |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS52133975A (ja) |
| BE (1) | BE854268A (ja) |
| DE (1) | DE2619638A1 (ja) |
| DK (1) | DK194377A (ja) |
| ES (1) | ES458264A1 (ja) |
| FR (1) | FR2372806A1 (ja) |
| GB (1) | GB1583163A (ja) |
| IT (1) | IT1086223B (ja) |
| NL (1) | NL7704739A (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4320136A (en) | 1980-08-11 | 1982-03-16 | E. I. Du Pont De Nemours And Company | 8-Aza-16,16-difluoroprostanoids |
| US4321201A (en) | 1980-09-22 | 1982-03-23 | E. I. Du Pont De Nemours And Company | Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates |
| JPH03500534A (ja) * | 1988-04-22 | 1991-02-07 | ２ モスコフスキ ゴスダルストベンニ メディツィンスキ インスティテュト イメニ エヌー．イー．ピロゴバ | ラクタム‐１‐酢酸カルボアルコキシメチルエステル及びその製造方法 |
| EE200200355A (et) * | 1999-12-22 | 2003-10-15 | Pfizer Products Inc. | EP4 retseptori selektiivsed agonistid osteoporoosi raviks |
| WO2002024647A1 (fr) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine |
| DE60130675T2 (de) | 2000-11-27 | 2008-01-24 | Pfizer Products Inc., Groton | Selektive agonisten des ep4 rezeptors für die behandlung von osteoporose |
| CA2451392A1 (en) * | 2001-07-16 | 2003-01-30 | F. Hoffmann-La Roche Ag | Prostaglandin analogues as ep4 receptor agonists |
| EP1408961B1 (en) | 2001-07-16 | 2007-07-11 | F. Hoffmann-La Roche Ag | 2 pyrrolidone derivatives as prostanoid agonists |
| KR100826866B1 (ko) | 2001-07-23 | 2008-05-06 | 오노 야꾸힝 고교 가부시키가이샤 | Ｅｐ４ 아고니스트를 유효 성분으로 하는 골량 저하질환의 치료제 |
| AU2003211574A1 (en) | 2002-03-05 | 2003-09-16 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| JP4754820B2 (ja) * | 2002-06-10 | 2011-08-24 | メルク セローノ ソシエテ アノニム | プロスタグランジン作動薬としてのγラクタムおよびその使用 |
| JP2006515015A (ja) | 2003-01-10 | 2006-05-18 | エフ．ホフマン−ラ ロシュ アーゲー | プロスタグランジンアゴニストとしての２−ピペリドン誘導体 |
| EP1586564B1 (en) * | 2003-01-21 | 2012-11-28 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivatives and medicinal uses thereof |
| US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| WO2006043655A1 (ja) * | 2004-10-22 | 2006-04-27 | Ono Pharmaceutical Co., Ltd. | 吸入用医薬組成物 |
| EP3176162B1 (en) | 2012-07-19 | 2020-05-27 | Cayman Chemical Company, Inc. | Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions |
| US9676712B2 (en) | 2013-03-15 | 2017-06-13 | Cayman Chemical Company, Inc. | Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions |
| SG11201507470WA (en) | 2013-03-15 | 2015-10-29 | Cayman Chemical Co Inc | Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions |
| US9914725B2 (en) | 2013-03-15 | 2018-03-13 | Cayman Chemical Company, Inc. | Methods of synthesizing a difluorolactam analog |
| CN105392505A (zh) | 2013-07-19 | 2016-03-09 | 开曼化学股份有限公司 | 用于促进骨生长的方法、系统和组合物 |
-
1976
- 1976-05-04 DE DE19762619638 patent/DE2619638A1/de active Pending
-
1977
- 1977-04-28 ES ES458264A patent/ES458264A1/es not_active Expired
- 1977-04-29 NL NL7704739A patent/NL7704739A/xx not_active Application Discontinuation
- 1977-05-02 IT IT23096/77A patent/IT1086223B/it active
- 1977-05-03 GB GB18427/77A patent/GB1583163A/en not_active Expired
- 1977-05-03 DK DK194377A patent/DK194377A/da unknown
- 1977-05-04 BE BE177278A patent/BE854268A/xx unknown
- 1977-05-04 JP JP5194577A patent/JPS52133975A/ja active Pending
- 1977-05-04 FR FR7713518A patent/FR2372806A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| GB1583163A (en) | 1981-01-21 |
| ES458264A1 (es) | 1978-07-16 |
| DE2619638A1 (de) | 1977-11-17 |
| JPS52133975A (en) | 1977-11-09 |
| FR2372806B1 (ja) | 1980-02-29 |
| IT1086223B (it) | 1985-05-28 |
| FR2372806A1 (fr) | 1978-06-30 |
| BE854268A (fr) | 1977-11-04 |
| NL7704739A (nl) | 1977-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK120077A (da) | Cycliske sulfonyloxiimider samt deres fremstilling og anvendelse | |
| DK194377A (da) | Pyrrolidoner samt deres fremstilling og anvendelse | |
| DK56876A (da) | Prostaglandinanaloge samt deres fremstilling og anvendelse | |
| DK248177A (da) | Guanidinderivater samt deres fremstilling og anvendelse | |
| DK287476A (da) | Pyrrolidoner samt deres fremstilling og anvendelse | |
| DK358678A (da) | 1,4-bis-amino-anthraquinonforbindelser samt deres anvendelse og fremstilling | |
| DK154877A (da) | Trans-hexahydro-pyrido-indoler samt deres fremstilling og anvendelse | |
| DK407577A (da) | Azabicycloforbindelser samt deres fremstilling og anvendelse | |
| DK97179A (da) | Bicyclooctanderivater samt deres fremstilling og anvendelse | |
| DK474678A (da) | Halogenvinyl-gamma-butyrolactoner samt deres fremstilling og anvendelse | |
| DK83677A (da) | Pyrrolbenzoxazalkaner samt deres fremstilling og anvendelse | |
| DK214577A (da) | Benzensulfonylurinstoffer deres fremstilling og anvendelse | |
| DK513678A (da) | Indolderivater samt deres fremstilling og anvendelse | |
| DK299578A (da) | Bleomyciner samt deres fremstilling og anvendelse | |
| DK581577A (da) | Dehydrooligopeptider samt deres fremstilling og anvendelse | |
| DK227177A (da) | 1-aryloxy-2-hydroxy-3-aminopropaner samt deres fremstilling og anvendelse | |
| DK254077A (da) | Benzylcyanocetaler deres fremstilling og anvendelse | |
| DK554776A (da) | Prostaglandinanaloge pyrrolidoner samt deres fremstilling og anvendelse | |
| DK279777A (da) | Carbostyriler samt deres fremstilling og anvendelse | |
| DK281476A (da) | Pyrrolidoner samt deres fremstilling og anvendelse | |
| DK565277A (da) | Imidazoliner deres fremstilling og anvendelse | |
| DK137778A (da) | Prostansyrederivater samt deres fremstilling og anvendelse | |
| DK574976A (da) | Substituerede cycloalkanpyrazoler samt deres fremstilling og anvendelse | |
| DK84377A (da) | Substituerede phenylguanidiner samt deres fremstilling og anvendelse | |
| DK582378A (da) | Simipermeable membraner samt deres fremstilling og anvendelse |